BQ-788

BQ-788 is an antagonist of Sphingosine Kinases used in studies of GPCR Signaling and Metabolic Signaling. In practice, this places the compound in experiments that measure receptor-driven second-messenger signaling and desensitization dynamics and metabolic regulation, energy sensing, and enzyme-linked homeostasis in cancer, cell signaling, and immunology models.

By blocking Sphingosine Kinases, BQ-788 can be used to examine receptor-driven second-messenger signaling and desensitization dynamics and metabolic regulation, energy sensing, and enzyme-linked homeostasis. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Sphingosine Kinases
• Pathway perturbation studies connected to GPCR Signaling and Metabolic Signaling
• Receptor-blockade and ligand-competition studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, BQ-788 is appropriate when a defined chemical perturbant is needed to connect Sphingosine Kinases with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.